1. Adrenaline-has a biphasic effect on intracellular lipoprotein lipase activity and on endogenous triacylglycerol content in heparin-perfused heart. 2. A high concentration of adrenaline (1I M in the perfusion buffer) activated endogenous lipoprotein lipase activity and, at the same time, decreased intracellular triacylglycerol stores. 3. In contrast, a low concentration (0.005,uM-adrenaline) inhibited intracellular lipoprotein lipase activity.
1. Adrenaline-has a biphasic effect on intracellular lipoprotein lipase activity and on endogenous triacylglycerol content in heparin-perfused heart. 2. A high concentration of adrenaline (1I M in the perfusion buffer) activated endogenous lipoprotein lipase activity and, at the same time, decreased intracellular triacylglycerol stores. 3. In contrast, a low concentration (0.005,uM-adrenaline) inhibited intracellular lipoprotein lipase activity.
Under these conditions, cardiac triacylglycerol content was elevated above control values. 4. Perfusing the heart with high and low concentrations of 3-isobutyl-1-methylxanthine elicited a biphasic effect on endogenous lipoprotein lipase activity and triacylglycerol content similar to that seen with adrenaline treatment. 5. The effect of adrenaline on intracellular lipoprotein lipase activity appears to be mediated by cyclic AMP through protein kinase. 6. A possible role for intracellular lipoprotein lipase in the regulation of endogenous triacylglycerol in rat heart is proposed.
In a previous study (Oscai, 1979) , suggestive evidence was provided to show that lipoprotein lipase acts as a regulator of intracellular triacylglycerols in the rat heart. In this previous study, glucagon caused marked alterations in the activity of lipoprotein lipase that correlated well with changes in the concentrations of triacylglycerol and nonesterified fatty acids in heart parenchymal cells. The results of the present investigation clearly demonstrate that adrenaline has a biphasic effect on intracellular lipoprotein-lipase activity and on endogenous triacylglycerol content similar to that seen with glucagon. In addition, the results show that our intracellular triacylglycerol lipase from heart has characteristics similar to those described for lipoprotein lipase (Korn, 1955a,b; Robinson, 1970; Borensztajn, 1979) . In separate experiments, evidence was provided to show that the effect of hormone on lipoprotein lipase activity is mediated by cyclic AMP, possibly through protein kinase.
Experimental

Treatment ofanimals
Male rats of a Wistar strain weighing approx. 90 g were purchased from Charles River (Wilmington, MA, U.S.A.). Animals were provided access to a diet of Purina chow and water ad libitum. They were permitted about 3 weeks to adapt to the living conditions in our animal quarters. At the time of killing, the rats weighed approx. 200g. The animal Vol. 198 room was maintained at a temperature between 21 and 230C and lighted between 07:30h and 19:30h. To control for oscillatory changes in cardiac triacylglycerol lipase activity (Kotlar & Borensztajn, 1977) , experiments were started at 08:15h and concluded by 10:15 h. After overnight starvation, the rats were anaesthetized with sodium pentobarbital (8-10mg/lOOg body wt.) and killed by removing the heart.
Heartperfusion
Hearts were isolated and perfused for 2min at a rate of 6 ml/min with Krebs-Ringer bicarbonate buffer (pH 7.4) containing 5% (v/v) rat serum and 5 units of heparin/ml to wash lipoprotein lipase, triacylglycerol, and non-esterified fatty acid from the capillary beds. At the end of the 2 min perfusion period, the perfusates were free from lipoprotein lipase activity, triacylglycerol and nonesterified fatty acid. The hearts were then perfused for 30min (6ml/min) with Krebs-Ringer bicarbonate buffer containing 5% rat serum and either adrenaline, N602'-dibutyryl cyclic AMP or 3-isobutyl-l-methylxanthine. Preliminary results showed that the capillary beds were lipoprotein lipase-free after the 30min perfusion period. Next, the hearts were perfused for 2 min at a rate of 6 ml/min with Krebs-Ringer bicarbonate buffer containing 5% rat serum to wash adrenaline, dibutyryl cyclic AMP or 3-isobutyl-1-methylxanthine from the capillary beds. Hearts were perfused in a non-recirculatory system 0306-3283/81/070159-08$01.50/1 ©) 1981 The Biochemical Society as described previously (Oscai, 1979) . The perfusion medium was continually gassed with 02/CO2 (19:1). The perfusion apparatus was housed in a temperature-regulated acrylic cabinet (Medical Research Apparatus, Clearwater, FL, U.S.A.) in which the temperature was maintained at 370C during the heart perfusions.
Heart homogenate preparation Hearts were isolated and perfused for 2 min at a rate of 6 ml/min with Krebs-Ringer bicarbonate buffer (pH 7.4) containing 5% rat serum and 5 units of heparin/ml to wash lipoprotein lipase, triacylglycerol and non-esterified fatty acid from the capillary beds. At the end of the 2min perfusion period, the perfusates were free from lipoprotein lipase activity, triacylglycerol and non-esterified fatty acid. Hearts were then homogenized and used for cyclic AMP, AMP or purified catalytic subunit of protein kinase experiments.
Assay methods
Lipoprotein lipase activity was measured by the assay described by Borensztajn et al. (1972) . Heparin-perfused hearts were homogenized in 0.025 M/NH3/HCI buffer (pH 8.1) with a Duall ground-glass grinder (Kontes Glass Co., Evanston, IL, U.S.A.). The tissue concentration of the homogenates was 50mg/ml. The composition of the assay medium and the procedures for incubation, extraction and measurement of unesterified fatty acids released into the assay medium have been described previously (Borensztajn et al., 1972 
Results
Adrenaline experiments
Hearts were perfused with luM-adrenaline. Under these conditions, lipoprotein lipase activity was elevated 2.2-fold, triacylglycerol decreased 62% and non-esterified fatty acid increased 3.5-fold (Table 1 ). In contrast, perfusing the heart with a low concentration of adrenaline (5 nM) caused a 70% decrease in intracellular lipoprotein lipase activity.
At the same time, triacylglycerols were elevated 73% above control values and non-esterified fatty acids were decreased by 80%. Fig. 1(a) shows a strong negative correlation between eiidogenous lipoprotein lipase activity and triacylglycerol content as a result of perfusing the heart with various concentrations of adrenaline. A strong positive correlation was obtained between intracellular lipoprotein lipase activity and cardiac non-esterified fatty acid (Fig. l b) . 3-Isobutyl-l-methylxanthine experiments Table 1 shows that perfusing the heart with 0.7mg of 3-isobutyl-1-methylxanthine/ml resulted in a 2.1-fold increase in intracellular lipoprotein lipase activity and a corresponding 69% decrease in endogenous triacylglycerol. Non-esterified fatty acids were increased 3.5-fold. On the other hand perfusing the heart with 0.005mg of 3-isobutyl-1-methylxanthine/ml caused an 85% decrease in intracellular lipoprotein lipase activity. Under these conditions, endogenous triacylglycerols were increased 2.5-fold and cardiac non-esterified fatty acids decreased 70%. Fig. 2 (a) shows a high negative correlation between intracellular lipoprotein lipase activity and the concentration of triacylglycerol as a result of perfusing the heart with various concentrations of 3-isobutyl-1-methylxanthine. A high positive correlation was obtained between endogenous lipoprotein lipase activity and cardiac non-esterified fatty acid (Fig. 2b ).
Adrenaline plus 3-isobutyl-1-methylxanthine experiments In preliminary dose-response experiments, maximal values for lipoprotein lipase activity were attained with concentrations of 1 UM for adrenaline and 0.7 mg/ml for 3-isobutyl-l-methylxanthine (Table 1) . When 1 uM-adrenaline and 0.7mg of 3-isobutyl-1-methylxanthine/ml were included in the perfusion buffer in combination, a new higher Adrenaline (0.005/UM) (4) 22 + 0.2* 3.10 + 0.10* 3-Isobutyl-l-methylxanthine (0.005 mg/ml) (5) 11 + 0.5* 4.44 + 0.10* Dibutyryl cyclic AMP (0.0025 mg/ml) (8) 22 + 1.0* 3.70 + 0.13* * Adrenaline, 3-isobutyl-l-methylxanthine or dibutyryl cyclic AMP versus control, P < 0.001. perfusion of the heart with a lower concentration of 3-isobutyl-1-methylxanthine (0.1mg/ml) yielded a submaximal value of 118+0.2units/g of tissue for lipoprotein lipase activity. In combination, these two agents (0.5 pM-adrenaline plus 0.1mg of 3-isobutyl-1-methylxanthine/ml) yielded a value of 144 + 0.5 units/g of tissue, which was higher than that elicited by either agent acting alone (P <0.001).
Dibutyryl cyclic AMP experiments Table 1 shows that 30min of perfusion of the heart with a high concentration of dibutyryl cyclic AMP (1 mg/ml) caused an approximate 2-fold increase in lipoprotein lipase activity. Under these experimental conditions, endogenous triacylglycerols were decreased 51% and non-esterified fatty acids were elevated 3-fold. In contrast, perfusion with a low concentration of dibutyryl cylic AMP (2.5,ug/ Fig. 3(a) shows a high negative correlation between enzyme activity and triacylglycerol concentration. In contrast, a high positive correlation was obtained between enzyme activity and nonesterified fatty acid content of the heart (Fig. 3b) . Cyclic AMP and AMP experiments Table 2 shows that a low concentration of cyclic AMP (1 nM) in the homogenization buffer resulted in a 70% decrease in lipoprotein lipase activity (P < 0.001). On the other hand, a high concentration of cyclic AMP (300pM) in the homogenizing medium caused a 93% increase in cardiac lipoprotein lipase activity (P < 0.001; Table 2 ). As shown in Table 2 , a small but statistically significant increase occurred in lipoprotein lipase activity (8%; P <0.001) with a low concentration of AMP in the homogenization buffer and, conversely, a small decrease in enzyme activity (11%; P < 0.001) with a high concentration of AMP in the homogenizing buffer.
Purified catalytic subunit ofprotein kinase experiments Characterization oflipoprotein lipase activity Table 4 shows the effects of serum and 1 M-NaCl on the lipolytic activities of the heart when assayed using cyclic AMP, protein kinase, dibutyryl cyclic AMP, adrenaline and 3-isobutyl-1-methylxanthine as stimulating agents. In the absence of serum, the inhibition varied from 68% to 92%. In the stimulated condition, the inhibition in the absence of serum was consistently between 110 and 115 units. The addition of 1 M-NaCl to the assay completely inhibited lipoprotein lipase activity regardless of the conditions (Table 4) . Figs. 4-6 show the effects of pH, heparin and protamine sulphate on the lipolytic activities of the heart when assayed using the same stimulating agents outlined above for serum and 1 M-NaCl. The results show that maximum levels of lipoprotein lipase activity were reached at pH8.1 (Fig. 4) and when the concentration of heparin was 14units/ml (Fig. 5 ). Fig. 6 shows that protamine sulphate (1 mg/ml) completely inhibited the lipolytic activities of the heart regardless of the experimental conditions. t 12.4 units of catalytic subunit of protein kinase was added to heart homogenate and mixed with one pass of the pestle.
t Hearts were perfused with 1 mg of dibutyryl cyclic AMP/ml. § Hearts were perfused with l1uM-adrenaline.
II Hearts were perfused with 0.7mg of 3-isobutyl-1-methylxanthine/ml.
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Discussion
Adrenaline has been shown to stimulate nonesterified fatty acid and glycerol release from the isolated perfused rat heart (Williamson, 1964; Challoner & Steinberg, 1965 , 1966 Kreisberg, 1966) . More recently, it was possible to demonstrate a decrease in the concentration of triacylglycerols as a result of perfusing the heart with catecholamines (Gartner & Vahouny, 1972; Crass, 1973; Crass et al., 1975) . The lipolytic effects of catecholamines and glucagon in heart appear to be mediated by cyclic AMP (Gartner & Vahouny, 1972; Crass, 1973; Lech et al., 1977) . However, although the 'hormone-sensitive lipase' from adipose tissue has been partially purified and has been Heparin (units/ml) Fig. 5 . The influence ofvarying the amounts ofheparin in the assay on lipoprotein lipase activity measured in homogenates ofheparin-perfused rat heart The heart received one of the following treatments: non-treated control (a); perfusion with l juM-adrenaline (b); perfusion with 0.7mg of 3-isobutyl-1-methylxanthine/ml (c); perfusion with 1mg of dibutyryl cyclic AMP/ml (d); homogenization with buffer containing 300#M-cyclic AMP (e); and addition of 12.4 units of protein kinase catalytic subunit (50,pl in 0.5mg of bovine serum albumin/ml) to 2ml of homogenate (f). Each point represents the mean for three hearts in (a) and two hearts in (b)-(f).
shown to be activated by cyclic AMP, a direct demonstration of the control of a cardiac lipase by cyclic AMP has not appeared (Lech et al., 1977) . Of considerable interest, therefore, are the results of the present study showing that perfusion of the heart with a high concentration of adrenaline caused an increase in the activity of intracellular lipoprotein lipase and, at the same time, a decrease in the concentration of endogenous triacylglycerol. Protamine sulphate (mg/ml) Fig. 6 . The influence of varying the amounts of protamine sulphate on lipoprotein lipase activity measured in homogenates ofheparin-perfused rat heart The heart received one of the following treatments:
non-treated control (a); perfusion with juM-adrenaline (b); perfusion with 0.7 mg of 3-isobutyl-1-methylxanthine/ml (c); perfusion with 1mg of dibutyryl cyclic AMP/ml (d); homogenization with buffer containing 300pM-cyclic AMP (e); and addition of 12.4 units of protein kinase catalytic subunit (SO1ul in 0.5mg of bovine serum albumin/ml) to 2 ml of homogenate (f). Each point represents the mean for five hearts in (a) and two hearts in (b)-(f).
inhibitor of cyclic AMP. In turn, Beavo et al. (1970) have reported that phosphodiesterase is inhibited by 3-isobutyl-1-methylxanthine. Thus an inhibition of phosphodiesterase activity by 3-isobutyl-1-methylxanthine would favour the accumulation of cyclic AMP. As a result, 3-isobutyl-1-methylxanthine was used as an additional probe to examine the role of lipoprotein lipase as a regulator of intracellular triacylglycerol in rat heart. The data obtained indicate that 3-isobutyl-1-methylxanthine exerts a biphasic effect on lipoprotein lipase activity and triacylglycerol content similar to that seen with adrenaline. Thus activation of lipoprotein lipase activity appears to promote triacylglycerol hydrolysis and, conversely, enzyme inhibition is accompanied by triacylglycerol accumulation above control values in the myocardium. These results are similar to those obtained in a previous study in vivo on cardiac lipoprotein lipase activity and triacylglycerol content in glucagontreated rats (Oscai, 1979) . A common denominator with respect to adrenaline, glucagon and 3-isobutyl-1-methylxanthine is that the intracellular effects of these agents are thought to be mediated by cyclic AMP. In keeping with this is the finding that perfusion of the heart with dibutyryl cyclic AMP produced a biphasic effect on intracellular lipoprotein lipase activity and on endogenous triacylglycerol content similar to that seen with adrenaline, glucagon and 3-isobutyl-1-methylxanthine. In the next series of experiments, heparin-perfused hearts were homogenized with buffer containing cyclic AMP or AMP. The results reveal that the activation and inhibition of lipoprotein lipase activity by cyclic AMP appears to be specific to cyclic AMP since AMP has no effect on enzyme activity.
A biphasic phenomenon in lipid metabolism has been described in humans. Eaton (1977) (Eaton, 1977 ). Sutherland's group proposed that in cyclic AMPregulated processes, when a hormone that induces cyclic AMP is administered in combination with a phosphodiesterase inhibitor, it should be possible to demonstrate an additive physiological effect (Robison et al., 1971) . Guided by such a criterion, we measured intracellular lipoprotein lipase activity in hearts of rats perfused with a combination of adrenaline and 3-isobutyl-1-methylxanthine. In combination, these two agents yielded higher values than could be elicited by either agent acting alone.
The first step in cyclic AMP action is generally thought to be the activation of cyclic AMP-dependent protein kinase The results of the present study raise some interesting questions and lay the groundwork for more specific studies of the biochemical processes involved. First, the addition of purified catalytic subunit of protein kinase to heart homogenate clearly stimulated lipoprotein lipase activity. Protein kinase catalyses the transfer of the y-phosphate group from ATP to serine and/or threonine residues on specific acceptor proteins. Thus protein kinasecatalysed phosphorylation has an ATP requirement. Yet, in the present study, cyclic AMP acting through protein kinase appeared to stimulate endogenous lipoprotein lipase activity resulting in cardiac triacylglycerol hydrolysis but in the absence of exogenous ATP in our assay system. At the present time, we do not have an explanation for the lack of an ATP requirement in the activation of lipoprotein lipase. However, we have not ruled out the possibility that protein kinase might be using endogenous ATP. Secondly, the addition of purified catalytic subunit of protein kinase to heart homogenate activated lipoprotein lipase activity at high concentrations but did not inhibit enzyme activity at low concentrations. Although detailed evidence is lacking, it appears that protein kinase is involved in the cyclic AMP stimulation of intracellular lipoprotein lipase activity, but is not involved in the cyclic AMP-related enzyme inhibition. Lukens & Borensztajn (1978) provide direct evidence that apoprotein C-II promotes the hydrolysis of chylomicron triacylglycerols by endothelium-bound lipoprotein lipase. At the present time, we cannot provide evidence for an intracellular activator of lipoprotein lipase similar to apoprotein C-II for lipoprotein lipase in the capillary beds. Although even the existence of an intracellular activator remains uncertain, it is clear from our results that our intracellular triacylglycerol lipase possesses many of the characteristics described for lipoprotein lipase. The common properties include alkaline pH optimum, serum requirement, activation by heparin, inhibition by high salt concentrations and inhibition by protamine sulphate (Borensztajn, 1979) .
Finally, it should be pointed out that Hahn (1943) first stimulated interest in a heparin-induced lipaemia clearing system. About 25 years ago, Korn (1955a,b) partially characterized a heparin-activated clearing factor and termed it 'lipoprotein lipase'. In the intervening years, the concept has developed that lipoprotein lipase functions exclusively as a clearing-factor lipase responsible for the hydrolysis of triacylglycerols from circulating chylomicrons and very-low-density lipoproteins (Robinson, 1970; Borensztajn, 1979) . It is attractive to think that lipoprotein lipase functions within the cell as a regulator of intracellular triacylglycerols in the rat myocardium. The evidence seems reasonably good that the actions of adrenaline and glucagon (Oscai, 1979) on intracellular lipoprotein lipase activity are mediated by cyclic AMP through protein kinase. Since it was possible to demonstrate hormone sensitivity and because lipoproteins do not exist in heart parenchymal cells, it may be more appropriate in the future to call this intracellular enzyme type L hormone-sensitive lipase.
